LGND
- Ligand Pharmaceuticals Incorporated
()
Overview
Company Summary
Ligand Pharmaceuticals Incorporated (LGND) is a biopharmaceutical company that specializes in providing innovative technologies and services to the pharmaceutical and biotechnology industries. The company operates under a unique business model, where it discovers and develops new drugs in partnership with other companies.
Ligand primarily focuses on the development of small molecule therapeutics, which are molecules that can be synthesized and are typically administered orally. These small molecules can target specific biological pathways or proteins in the human body, enabling the treatment of various diseases and medical conditions.
One of the key aspects of Ligand's business model is its proprietary technology platforms. Ligand has developed technologies that aid in drug discovery, enhance drug delivery, and improve the overall efficacy of therapeutics. These platforms include the Captisol� platform for formulating complex drugs, the OmniAb� platform for generating fully human antibodies, and the Vernalis Design platform for structure-based drug discovery.
In addition to its internal drug development efforts, Ligand also generates revenue through partnerships and collaborations with other pharmaceutical and biotechnology companies. These collaborations involve providing access to Ligand's technology platforms, allowing its partners to discover, develop, and commercialize new therapeutic drugs.
Ligand's diverse product portfolio covers a range of therapeutic areas including oncology, immunology, metabolic diseases, and central nervous system disorders. The company's drugs are used in the treatment of multiple conditions, such as cancer, rheumatoid arthritis, metabolic disorders, and respiratory diseases.
Overall, Ligand Pharmaceuticals Incorporated plays a vital role in the pharmaceutical and biotechnology industries by providing innovative technologies and partnering with companies to develop new and effective therapeutic treatments for various diseases.